Allstate Investment Management’s Medtronic MDT Stock Holding History

Allstate Investment Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4.38M	Buy	+56,324	New	+$4.56M	0.13%	110

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Allstate Investment Management's MDT Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Medtronic (MDT) in Q4 2022: 56,324 shares worth $4.38M. The stake represents 0.13% of the portfolio and ranks #110 among its holdings.

1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Allstate Investment Management held 56,324 shares of Medtronic worth $4.38M as of Q4 2022.
Medtronic was a new Allstate Investment Management position in Q4 2022.
Medtronic made up 0.13% of Allstate Investment Management's portfolio in Q4 2022, its #110 holding.
1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.